Abstract
Prenatally acquired human cytomegalovirus (HCMV) infection is the most frequent viral infection of newborns in developed countries. Virostatic therapy is accompanied by side effects and stepwise emergence of resistant virus variants. Different genotypic approaches show limited sensitivity in detecting on-growing minor resistant virus populations. Here, we demonstrate the superiority of pyrosequencing for the monitoring of mutant emergence. In a preterm baby born after 28 weeks of gestation and suffering from disseminated congenital HCMV infection, long-term control could not be achieved under ganciclovir/valganciclovir therapy and the infant died on the 113th day of life. Resistance-associated mutations in the HCMV UL97 gene were not detected by conventional DNA sequencing but postmortem pyrosequencing. Four different CMV variants carrying resistance-associated mutations each representing 11–17% of the total CMV population were found.
Similar content being viewed by others
References
Schleiss MR, McVoy MA (2004) Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. Expert Rev Anti Infect Ther 2:389–403
Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF (1999) Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 104:55–60
Kimberlin DW, Lin CY, Sanchez PJ et al (2003) Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 143:16–25
Schuurman R, Demeter L, Reichelderfer P, Tijnagel J, de Groot T, Boucher C (1999) Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase. J Clin Microbiol 37:2291–2296
Ronaghi M (2001) Pyrosequencing sheds light on DNA sequencing. Genome Res 11:3–11
Fox S, Filichkin S, Mockler TC (2009) Applications of ultra-high-throughput sequencing. Methods Mol Biol 553:79–108
Mori T, Okamoto S, Matsuoka S et al (2000) Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 25:765–769
Prix L, Hamprecht K, Holzhuter B, Handgretinger R, Klingebiel T, Jahn G (1999) Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child. J Infect Dis 180:491–495
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467
Schindele B, Apelt L, Hofmann J et al (2010) Improved detection of mutated HCMV UL97 by pyrosequencing. Antimicrob Agents Chemother (in press)
Galli L, Novelli A, Chiappini E et al (2007) Valganciclovir for congenital CMV infection: a pilot study on plasma concentration in newborns and infants. Pediatr Infect Dis J 26:451–453
Gilbert C, Boivin G (2005) Human cytomegalovirus resistance to antiviral drugs. Antimicrob Agents Chemother 49:873–883
Bousfiha A, Picard C, Boisson-Dupuis S et al (2010) Primary immunodeficiencies of protective immunity to primary infections. Clin Immunol 135:204–209
Casrouge A, Zhang SY, Eidenschenk C et al (2006) Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:308–312
Zhang SY, Jouanguy E, Ugolini S et al (2007) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522–1527
Bassiri H, Janice Yeo WC, Rothman J et al (2008) X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses. Immunol Res 42:145–159
Castor J, Cook L, Corey L et al (2007) Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance. J Clin Microbiol 45:2681–2683
Chou S (2008) Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir. Rev Med Virol 18:233–246
Acknowledgments
The authors wish to thank Dr. M. Raftery (Institute of Medical Virology Charité, Berlin) for critical reading of the manuscript. Expert technical assistance by Mrs. C. Stephan, S. Liebmann, and C. Walter is gratefully acknowledged.
Conflict of interest
The authors have declared that no conflict of interests exist.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kampmann, S.E., Schindele, B., Apelt, L. et al. Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection. Med Microbiol Immunol 200, 109–113 (2011). https://doi.org/10.1007/s00430-010-0181-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-010-0181-y